Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$17.59 - $23.83 $5.28 Million - $7.15 Million
-300,000 Reduced 15.62%
1,621,118 $31.6 Billion
Q4 2020

Aug 11, 2021

BUY
$15.75 - $25.45 $30.3 Million - $48.9 Million
1,921,118 New
1,921,118 $33.5 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.73B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track River Vest Venture Management LLC Portfolio

Follow River Vest Venture Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Vest Venture Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Vest Venture Management LLC with notifications on news.